4//SEC Filing
Tessari Eben 4
Accession 0001867899-25-000005
CIK 0001730430other
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 4:44 PM ET
Size
9.2 KB
Accession
0001867899-25-000005
Insider Transaction Report
Form 4
Tessari Eben
CHIEF OPERATING OFFICER
Transactions
- Sale
Class A Ordinary Share
2025-09-29$38.33/sh−42,000$1,609,860→ 34,552 total - Exercise/Conversion
Share Option
2025-09-29−42,000→ 0 totalExercise: $17.92Exp: 2029-03-03→ Class A Ordinary Share (42,000 underlying) - Exercise/Conversion
Class A Ordinary Share
2025-09-29$17.92/sh+42,000$752,640→ 76,552 total
Footnotes (3)
- [F1]This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on April 29, 2024.
- [F2]This transaction was executed in multiple trades through a broker-dealer at prices ranging between $37.92 and $38.85. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- [F3]The option is fully vested and exercisable.
Documents
Issuer
Kiniksa Pharmaceuticals International, plc
CIK 0001730430
Entity typeother
Related Parties
1- filerCIK 0001867899
Filing Metadata
- Form type
- 4
- Filed
- Sep 30, 8:00 PM ET
- Accepted
- Oct 1, 4:44 PM ET
- Size
- 9.2 KB